Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06903078 · ClinicalTrials.gov registry record
A Study That Collects Participant Data and Biospecimens to Analyze Pathogenic Exosomes That Mediate Increased Vascular Dementia Risk in Individuals With Herpes Zoster.
A clinical trial of Vascular Dementia and Herpes Zoster (HZ), sponsored by Center for Clinical Studies, Texas.
- Recruiting
- Registry status
- 375
- Enrollment target
- 2
- Study locations
NCT06903078 is a study of Vascular Dementia and Herpes Zoster (HZ) that is actively recruiting participants, run by Center for Clinical Studies, Texas. The registered enrollment target is 375 participants, below the 1,160-participant average among 10 other Vascular Dementia trials with a reported enrollment target (68% lower). The trial reports 2 study locations across 1 state.
The verdict
NCT06903078, a study of Vascular Dementia and Herpes Zoster (HZ), is actively recruiting participants, sponsored by Center for Clinical Studies, Texas.
- RECRUITING
- Registry status
- 375 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of this observational research study is to study if patients with herpes zoster, also known as Shingles, have a higher risk of vascular dysfunction (problems with blood vessels, including stroke) and vascular dementia (problems with mental decline as a result of decreased blood flow to the brain) compared to patients without herpes zoster. Patients are evaluated based on the group they are assigned too: 1. Herpes Zoster (HZ) Group: individuals presenting with untreated herpes zoster. These participants will have 6 visits: * Day 1 = 1st day presenting to clinic with acute zoster * 7 days post zoster * 1 month after Day 1 * 3 months after Day 1 * 6 months after Day 1 * 12 months after Day 1 2. Control Group: individuals without herpes zoster o Day 1 (only 1 visit will be completed) This study does not have a study medication/device. Standard of care for all patients will be followed.
Conditions Studied
Study Locations (2)
Texas
- Center for Clinical Studies, LTD. LLP - Houston
- Center for Clinical Studies, LTD. LLP - Webster
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 375 participants |
| Start Date | 2025-02-13 |
| Est. Completion | 2030-08 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06903078
The ClinicalTrials.gov registry entry for NCT06903078 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 375 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,160-participant average among 10 other Vascular Dementia trials with a reported enrollment target (68% lower). The listed sponsor is Center for Clinical Studies, Texas, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Vascular Dementia appearing as the primary indexed condition, and to 0 interventions.
NCT06903078 reports 2 study locations spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT06903078 about?
NCT06903078 is a clinical study titled "A Study That Collects Participant Data and Biospecimens to Analyze Pathogenic Exosomes That Mediate Increased Vascular Dementia Risk in Individuals With Herpes Zoster.". The purpose of this observational research study is to study if patients with herpes zoster, also known as Shingles, have a higher risk of vascular dysfunction (problems with blood vessels, including stroke) and vascular dementia (problems with mental decline as a result of decreased blood flow to t...
What is the current status of trial NCT06903078?
This trial is currently recruiting. The enrollment target is 375 participants. The study started on 2025-02-13. Estimated completion is 2030-08.
What conditions does trial NCT06903078 study?
This clinical trial studies the following conditions: Vascular Dementia, Herpes Zoster (HZ).
Who is sponsoring clinical trial NCT06903078?
This trial is sponsored by Center for Clinical Studies, Texas, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06903078 being conducted?
This trial has 2 study locations across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Vascular Dementia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Longitudinal Cognitive Assessment by BoCA
RECRUITING
-
Pulsed Electromagnetic Field Treatment With Dementia Patients
RECRUITING · NA
-
Cognitive and Vascular Functioning Following TBI
RECRUITING
-
The BRAIN App (Phase 2 SBIR)
RECRUITING · NA
-
Florida Cerebrovascular Disease Biorepository and Genomics Center
ACTIVE NOT RECRUITING
-
Telehealth-enabled Integrated Palliative Care for People With Dementia
COMPLETED · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.